Biohaven (BHVN) had its price target raised by TD Cowen from $15.00 to $30.00. They now have a "buy" rating on the stock.
Biohaven (BHVN) had its "strong-buy" rating reaffirmed by Raymond James Financial, Inc..
Biohaven (BHVN) had its price target lowered by HC Wainwright from $11.00 to $10.00. They now have a "neutral" rating on the stock.
Biohaven (BHVN) had its "outperform" rating reaffirmed by Leerink Partners.
Biohaven (BHVN) had its price target raised by Royal Bank Of Canada from $22.00 to $23.00. They now have an "outperform" rating on the stock.